American Society of Clinical Oncology

Oncology & Cancer

Androgen receptor abnormality may not be associated

Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). ...

Oncology & Cancer

New therapies harness power of the immune system against cancer

New research on innovative immunotherapies for advanced or high-risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). These treatments – used ...

page 4 from 7